Abstract:Purpose: To evaluate characteristics of obstructions of the hepatic veins (HVs) in Chinese patients, technical aspects of puncture of the HVs, short- and mid-term outcomes, and complications of endovascular treatment.Patients and Methods: Forty-eight HV patients with different degrees of symptoms and signs of portal hypertension were enrolled in our study. Endovascular treatments with balloon and stents were performed. Catheter-directed thrombolysis (CDT) was performed in patients with thrombosis in the HVs. For patients with lesions of both the HVs and the inferior vena cava (IVC), balloon expansions or stenting were performed at the IVC lesions also.Results: Endovascular treatments were successful in 43 patients. The technically success rate was 89.6% (43/48). Fifteen patients underwent solely balloon expansions, 28 patients had balloon expansions and stentings, 5 patients underwent CDT, and 3 patients had implanted stents in the IVC lesions at the same time. The symptoms of portal hypertension were alleviated in 39 patients postoperatively. In the other 4 cases portal hypertension was mildly alleviated at discharge. Thirty-nine of the 43 patients were followed up for an average of 24 +/- 1.3 months (range, 6-62 months). Ascites were completely resolved in 32 cases, with a small amount of ascites in 4 patients and moderate to massive amounts in 3 patients. Hepatomegaly and splenomegaly completely disappeared in 30 patients and still could be touched in 6 patients. The HVs were patent in 29 patients. Restenosis and re-occlusion of the HVs appeared in 4 cases. All patients were successfully treated by endovascular treatments.Conclusions: Endovascular treatments for patients with obstruction of the HVs have a high technical success rate, fewer complications, and better short- and mid-term clinical outcome. The key to successful endovascular treatment is successful puncture of HVs. For patients who have occlusive lesions of HVs combined with occlusive IVC, recanalization of the lesions of the HVs could achieve good results.

A Contrastive Study of Two Kind of Balloon Catheters in Treatment of Budd-Chiari Syndrome

Balloon Angloplasty and Stenting of Hepatic Veins for the Treatment of Budd-Chiari Syndrome Caused by Long Segmental Occlusion of the Inferior Vena Cava (IVC)

Interventional Endovascular Treatment for Budd-Chiari Syndrome Using Percutaneous Transluminal Angioplasty and Stents

INTERVENTIONAL OR SEMI-INTERVENTIONAL TREATMENT FOR BUDD-CHIARI SYNDROME

Application of percutaneous transluminal balloon dilatation in patients with catheter-related central vein disease

Staged Management of Budd-Chiari Syndrome Caused by Co-Obstruction of the Inferior Vena Cava and Main Hepatic Veins.

Endovascular Treatment Of Budd-Chiari Syndrome With Hepatic Vein Obstruction In China

Paclitaxel Coated Balloon Versus Conventional Balloon Angioplasty in Dysfunctional Dialysis Arteriovenous Fistula: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Study on the effects of percutaneaus selective isolated hepatic perfusion with new double balloon catheter

[Application of Percutaneous Transluminal Angioplasty and Stent Placement at the Third Hepatic Porta in Treatment of Budd-Chiari Syndrome].

Significance of accessory hepatic vein pressure reduction in treatment of Budd-Chiari syndrome

Utility of hepatic vein waveform and transient elastography in patients with Budd-Chiari syndrome who require angioplasty: Two case reports

Endovascular treatment of Budd-Chiari syndrome with occlusion of hepatic veins

Inferior Vena Cava Dilatation and Stent Implantation Combined with Splenorenal Shunt to Treat Budd-Chiari Syndrome

Interventional and Surgical Treatment of Budd-Chiari Syndrome: A Report of 39 Cases

Endovascular treatment of segmental occlusive Budd-Chiari syndrome

Modified Transjugular Intrahepatic Portosystemic Shunt In The Treatment Of Budd-Chiari Syndrome

Analysis the clinical efficacy of portal vein system thrombosis treated in three different interventional procedures

Interventional Treatment of Budd-Chiari Syndrome:Report of 312 Cases

Anticoagulation with warfarin for Budd-Chiari syndrome with chronic inferior vena cava thrombosis: an initial clinical experience.